Differential effects of procaspase-3 activating compounds in the induction of cancer cell death

Molecular Pharmaceutics

Volumn 9, Issue 5, 2012, Pages 1425-1434

  West, Diana C ^a   Qin, Yan ^c   Peterson, Quinn P ^b   Thomas, Diana L ^a   Palchaudhuri, Rahul ^a   Morrison, Karen C ^a   Lucas, Pamela W ^a   Palmer, Amy E ^c   Fan, Timothy M ^a   Hergenrother, Paul J ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

apoptosis; blood brain barrier; bolus dose; calcium release; constant rate infusion; ER stress; punctate mitochondria; small molecule; transcript profiling; zinc chelation

Indexed keywords

CALCIUM ION; DUAL SPECIFICITY PHOSPHATASE 2; PROCASPASE 3; S PAC 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL DEATH; CELL STRUCTURE; CONCENTRATION (PARAMETERS); ENDOPLASMIC RETICULUM; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; CALCIUM; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; DOGS; FEMALE; HELA CELLS; HL-60 CELLS; HUMANS; HYDRAZONES; MICE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PIPERAZINES; ZINC;

EID: 84860785721     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200673n     Document Type: Article

References (62)

1. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100, 57-70
2. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation Cell 2011, 144, 646-674
3. Vassilev, L. T.; Vu, B. T.; Graves, B.; Carvajal, D.; Podlaski, F.; Filipovic, Z.; Kong, N.; Kammlott, U.; Lukacs, C.; Klein, C.; Fotouhi, N.; Liu, E. A. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 2004, 303, 844-848
4. Tovar, C.; Rosinski, J.; Filipovic, Z.; Higgins, B.; Kolinsky, K.; Hilton, H.; Zhao, X.; Vu, B. T.; Qing, W.; Packman, K.; Myklebost, O.; Heimbrook, D. C.; Vassilev, L. T. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 1888-1893
5. Oltersdorf, T.; Elmore, S. W.; Shoemaker, A. R.; Armstrong, R. C.; Augeri, D. J.; Belli, B. A.; Bruncko, M.; Deckwerth, T. L.; Dinges, J.; Hajduk, P. J.; Joseph, M. K.; Kitada, S.; Korsmeyer, S. J.; Kunzer, A. R.; Letai, A.; Li, C.; Mitten, M. J.; Nettesheim, D. G.; Ng, S.; Nimmer, P. M.; O'Connor, J. M.; Oleksijew, A.; Petros, A. M.; Reed, J. C.; Shen, W.; Tahir, S. K.; Thompson, C. B.; Tomaselli, K. J.; Wang, B.; Wendt, M. D.; Zhang, H.; Fesik, S. W.; Rosenberg, S. H. An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 2005, 435, 677-681
6. Sun, H.; Nikolovska-Coleska, Z.; Yang, C. Y.; Qian, D.; Lu, J.; Qiu, S.; Bai, L.; Peng, Y.; Cai, Q.; Wang, S. Design of small-molecule peptidic and nonpeptidic Smac mimetics Acc. Chem. Res. 2008, 41, 1264-1277
7. Roy, S.; Bayly, C. I.; Gareau, Y.; Houtzager, V. M.; Kargman, S.; Keen, S. L.; Rowland, K.; Seiden, I. M.; Thornberry, N. A.; Nicholson, D. W. Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 6132-6137
8. O'Donovan, N.; Crown, J.; Stunell, H.; Hill, A. D.; McDermott, E.; O'Higgins, N.; Duffy, M. J. Caspase 3 in breast cancer Clin. Cancer Res. 2003, 9, 738-742
9. Krepela, E.; Prochazka, J.; Liul, X.; Fiala, P.; Kinkor, Z. Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma Biol. Chem. 2004, 385, 153-168
10. Jiang, H.; Gong, M.; Cui, Y.; Ma, K.; Chang, D.; Wang, T. Y. Upregulation of caspase-3 expression in esophageal cancer correlates with favorable prognosis: an immunohistochemical study from a high incidence area in northern China Dis. Esophagus 2010, 23, 487-492
11. Fink, D.; Schlagbauer-Wadl, H.; Selzer, E.; Lucas, T.; Wolff, K.; Pehamberger, H.; Eichler, H. G.; Jansen, B. Elevated procaspase levels in human melanoma Melanoma Res. 2001, 11, 385-393
12. Izban, K. F.; Wrone-Smith, T.; Hsi, E. D.; Schnitzer, B.; Quevedo, M. E.; Alkan, S. Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease Am. J. Pathol. 1999, 154, 1439-1447
13. Wrobel, G.; Maldyk, J.; Kazanowska, B.; Rapala, M.; Maciejka-Kapuscinska, L.; Chaber, R. Immunohistochemical expression of procaspase-3 and its clinical significance in childhood non-Hodgkin lymphomas Pediatr. Dev. Pathol. 2011, 14, 173-179
14. Putt, K. S.; Chen, G. W.; Pearson, J. M.; Sandhorst, J. S.; Hoagland, M. S.; Kwon, J. T.; Hwang, S. K.; Jin, H.; Churchwell, M. I.; Cho, M. H.; Doerge, D. R.; Helferich, W. G.; Hergenrother, P. J. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy Nat. Chem. Biol. 2006, 2, 543-550
15. Peterson, Q. P.; Goode, D. R.; West, D. C.; Ramsey, K. N.; Lee, J.; Hergenrother, P. J. PAC-1 Activates Procaspase-3 in Vitro through Relief of Zinc-Mediated Inhibition J. Mol. Biol. 2009, 388, 144-158
16. Lucas, P. W.; Schmit, J. M.; Peterson, Q. P.; West, D. C.; Hsu, D. C.; Novotny, C. J.; Dirikolu, L.; Churchwell, M. I.; Doerge, D. R.; Garrett, L. D.; Hergenrother, P. J.; Fan, T. M. Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs Invest. New Drugs 2011, 29, 901-911
17. Peterson, Q. P.; Hsu, D. C.; Novotny, C. J.; West, D. C.; Kim, D.; Schmit, J. M.; Dirikolu, L.; Hergenrother, P. J.; Fan, T. M. Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound Cancer Res. 2010, 70, 7232-7241
18. Peterson, Q. P.; Hsu, D. C.; Goode, D. R.; Novotny, C. J.; Totten, R. K.; Hergenrother, P. J. Procaspase-3 Activation as an Anti-Cancer Strategy: Structure-Activity Relationship of PAC-1, and its Cellular Co-Localization with Procaspase-3 J. Med. Chem. 2009, 52, 5721-5731
19. Hsu, D. C.; Roth, H. S.; West, D. C.; Botham, R. C.; Novotny, C. J.; Schmid, S. C.; Hergenrother, P. J. Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1) ACS Comb. Sci. 2012, 14, 44-50
20. Wolan, D. W.; Zorn, J. A.; Gray, D. C.; Wells, J. A. Small-molecule activators of a proenzyme Science 2009, 326, 853-858
21. Zorn, J. A.; Wille, H.; Wolan, D. W.; Wells, J. A. Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation J. Am. Chem. Soc. 2011, 133, 19630-19633
22. Qin, Y.; Dittmer, P. J.; Park, J. G.; Jansen, K. B.; Palmer, A. E. Measuring steady-state and dynamic endoplasmic reticulum and Golgi Zn2+ with genetically encoded sensors Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 7351-7356
23. 2+ indicators based on computationally redesigned calmodulin-peptide pairs Chem. Biol. 2006, 13, 521-530
24. 2+ analyzed with an improved genetically encoded fluorescent sensor Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17404-17409
25. Bair, J. S.; Palchaudhuri, R.; Hergenrother, P. J. Chemistry and biology of deoxynyboquinone, a potent inducer of cancer cell death J. Am. Chem. Soc. 2010, 132, 5469-5478
26. Dittmer, P. J.; Miranda, J. G.; Gorski, J. A.; Palmer, A. E. Genetically encoded sensors to elucidate spatial distribution of cellular zinc J. Biol. Chem. 2009, 284, 16289-16297
27. 2+ J. Biol. Chem. 1985, 260, 2719-2727
28. Palchaudhuri, R.; Hergenrother, P. J. Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential ACS Chem. Biol. 2011, 6, 21-33
29. Keum, C.; Woo, J. H.; Oh, W. S.; Park, S. N.; No, K. T. Improving gene expression similarity measurement using pathway-based analytic dimension BMC Genomics 2009, 10 (Suppl. 3) S15
30. Das, S. K.; Mondal, A. K.; Elbein, S. C. Distinct gene expression profiles characterize cellular responses to palmitate and oleate J. Lipid Res. 2010, 51, 2121-2131
31. Oyadomari, S.; Mori, M. Roles of CHOP/GADD153 in endoplasmic reticulum stress Cell Death Differ. 2004, 11, 381-389
32. Kokame, K.; Agarwala, K. L.; Kato, H.; Miyata, T. Herp, a new ubiquitin-like membrane protein induced by endoplasmic reticulum stress J. Biol. Chem. 2000, 275, 32846-32853
33. Lamb, J.; Crawford, E. D.; Peck, D.; Modell, J. W.; Blat, I. C.; Wrobel, M. J.; Lerner, J.; Brunet, J. P.; Subramanian, A.; Ross, K. N.; Reich, M.; Hieronymus, H.; Wei, G.; Armstrong, S. A.; Haggarty, S. J.; Clemons, P. A.; Wei, R.; Carr, S. A.; Lander, E. S.; Golub, T. R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 2006, 313, 1929-1935
34. Treiman, M.; Caspersen, C.; Christensen, S. B. A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases Trends Pharmacol. Sci. 1998, 19, 131-135
35. Szegezdi, E.; Logue, S. E.; Gorman, A. M.; Samali, A. Mediators of endoplasmic reticulum stress-induced apoptosis EMBO Rep. 2006, 7, 880-885
36. Li, G.; Mongillo, M.; Chin, K. T.; Harding, H.; Ron, D.; Marks, A. R.; Tabas, I. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis J. Cell Biol. 2009, 186, 783-792
37. Norinder, U.; Haeberlein, M. Computational approaches to the prediction of the blood-brain distribution Adv. Drug Delivery Rev. 2002, 54, 291-313
38. Clark, D. E. In silico prediction of blood-brain barrier permeation Drug Discovery Today 2003, 8, 927-933
39. Hitomi, J.; Katayama, T.; Taniguchi, M.; Honda, A.; Imaizumi, K.; Tohyama, M. Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12 Neurosci. Lett. 2004, 357, 127-130
40. Chiang, P. C.; Chien, C. L.; Pan, S. L.; Chen, W. P.; Teng, C. M.; Shen, Y. C.; Guh, J. H. Induction of endoplasmic reticulum stress and apoptosis by a marine prostanoid in human hepatocellular carcinoma J. Hepatol. 2005, 43, 679-686
41. Linder, S.; Shoshan, M. C. Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy Drug Resist. Updates 2005, 8, 199-204
42. i in fibroblasts J. Cell Sci. 1997, 110, 2227-2238
43. Hom, J. R.; Gewandter, J. S.; Michael, L.; Sheu, S. S.; Yoon, Y. Thapsigargin induces biphasic fragmentation of mitochondria through calcium-mediated mitochondrial fission and apoptosis J. Cell. Physiol. 2007, 212, 498-508
44. 2+ in rat ventricular myocytes Biochim. Biophys. Acta 2010, 1797, 913-921
45. 2+: a control point for apoptosis Science 2003, 300, 135-139
46. Rao, R. V.; Castro-Obregon, S.; Frankowski, H.; Schuler, M.; Stoka, V.; del Rio, G.; Bredesen, D. E.; Ellerby, H. M. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway J. Biol. Chem. 2002, 277, 21836-21842
47. Shore, G. C.; Papa, F. R.; Oakes, S. A. Signaling cell death from the endoplasmic reticulum stress response Curr. Opin. Cell Biol. 2011, 23, 143-149
48. Perocchi, F.; Gohil, V. M.; Girgis, H. S.; Bao, X. R.; McCombs, J. E.; Palmer, A. E.; Mootha, V. K. MICU1 encodes a mitochondrial EF hand protein required for Ca(2+) uptake Nature 2010, 467, 291-296
49. Seervi, M.; Joseph, J.; Sobhan, P. K.; Bhavya, B. C.; Santhoshkumar, T. R. Essential requirement of cytochrome c release for caspase activation by procaspase-activating compound defined by cellular models Cell Death Dis. 2011, 2, e207 210.1038/cddis.2011.1090
50. Buckley, B. J.; Whorton, A. R. Tunicamycin increases intracellular calcium levels in bovine aortic endothelial cells Am. J. Physiol. 1997, 273, C1298-1305
51. Breckenridge, D. G.; Stojanovic, M.; Marcellus, R. C.; Shore, G. C. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol J. Cell Biol. 2003, 160, 1115-1127
52. Chandra, D.; Choy, G.; Deng, X.; Bhatia, B.; Daniel, P.; Tang, D. G. Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death Mol. Cell. Biol. 2004, 24, 6592-6607
53. Yoneda, T.; Imaizumi, K.; Oono, K.; Yui, D.; Gomi, F.; Katayama, T.; Tohyama, M. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress J. Biol. Chem. 2001, 276, 13935-13940
54. Upton, J. P.; Austgen, K.; Nishino, M.; Coakley, K. M.; Hagen, A.; Han, D.; Papa, F. R.; Oakes, S. A. Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress Mol. Cell. Biol. 2008, 28, 3943-3951
55. Moenner, M.; Pluquet, O.; Bouchecareilh, M. Chevet, E., Integrated endoplasmic reticulum stress responses in cancer Cancer Res. 2007, 67, 10631-10634
56. Leleu, X.; Xu, L.; Jia, X.; Sacco, A.; Farag, M.; Hunter, Z. R.; Moreau, A. S.; Ngo, H. T.; Hatjiharissi, E.; Ho, A. W.; Santos, D. D.; Adamia, S.; O'Connor, K.; Ciccarelli, B.; Soumerai, J.; Manning, R. J.; Patterson, C. J.; Roccaro, A. M.; Ghobrial, I. M.; Treon, S. P. Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia Blood 2009, 113, 626-634
57. Verfaillie, T.; Garg, A. D.; Agostinis, P. Targeting ER stress induced apoptosis and inflammation in cancer Cancer Lett. 2010, 10.1016/j.canlet.2010. 1007.1016
58. Schleicher, S. M.; Moretti, L.; Varki, V.; Lu, B. Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: implications for future therapeutic approaches Drug Resist. Updates 2010, 13, 79-86
59. Peiro, C.; Vallejo, S.; Cercas, E.; Llergo, J. L.; Lafuente, N.; Matesanz, N.; Rodriguez-Manas, L.; Sanchez-Ferrer, C. F. Thapsigargin induces apoptosis in cultured human aortic smooth muscle cells J. Cardiovasc. Pharmacol. 2000, 36, 676-680
60. Carlberg, M.; Dricu, A.; Blegen, H.; Kass, G. E.; Orrenius, S.; Larsson, O. Short exposures to tunicamycin induce apoptosis in SV40-transformed but not in normal human fibroblasts Carcinogenesis 1996, 17, 2589-2596
61. Shah, N. P.; Kasap, C.; Weier, C.; Balbas, M.; Nicoll, J. M.; Bleickardt, E.; Nicaise, C.; Sawyers, C. L. Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis Cancer Cell 2008, 14, 485-493
62. Saglio, G.; Hochhaus, A.; Goh, Y. T.; Masszi, T.; Pasquini, R.; Maloisel, F.; Erben, P.; Cortes, J.; Paquette, R.; Bradley-Garelik, M. B.; Zhu, C.; Dombret, H. Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 mg once daily and 70 mg twice daily Cancer 2010, 116, 3852-3861